Anonymous ID: f72d23 Oct. 5, 2020, 8:05 a.m. No.10932028   🗄️.is 🔗kun   >>2038 >>2068 >>2244 >>2317 >>2402

So I was wondering why the heck Trump is said to be taking remdesivir when its so expensive, rather than HCQ+Z pack and showing that off.

 

I guess its showing that treatments vaccine

 

Thoughts on that and the whole remdesivir thing in general?

Anonymous ID: f72d23 Oct. 5, 2020, 8:41 a.m. No.10932408   🗄️.is 🔗kun   >>2432 >>2557

Guys, just heard a theory that needs a little digging on I think.

 

>Remdesivir is a HCQ ionophore with a patent. Zinc is the active component.

 

>Do you remember reading the article Fauci wrote in 2005 saying HCQ was not only a cure, but a vaccine for Corona viruses?

>Guess who is heavily invested in the very expensive >Remdesivir? Fauci!

>So they took HCQ made a few tweaks, added Zinc and got a patent.

 

Thoughts on this?

Anonymous ID: f72d23 Oct. 5, 2020, 8:56 a.m. No.10932584   🗄️.is 🔗kun

Found this too

 

https://hardnoxandfriends.com/2020/08/17/from-one-of-our-readers-about-remdesivir/

 

The following is a letter sent to Noxandfriends, from a biochemist, E.J.Ledet, who did some looking into Remdisivir.. We will let you make up your own mind on this without commenting…

 

Subject: Remdesivir is a ligand ionophore transporter of zinc

 

Comment: We believe that HCQ is in direct competition with Remdesivir and that Gilead, Big Pharma has put a lot of $$ pressure on MDs, Medical Journals, Press, Academia, NIH, CDC to discredit HCQ after 65 yrs of safe use as a malaria drug and 40 years of safe use to treat lupus and some forms of arthritis.

 

Gilead contributes $$$ to the income of 20% of NIH Board MDs and Fauci heads NIH. Gilead also funds a great deal of $$$ to Academia Medical research and $$ to Medical journal publishers. The ZInc15 Ligand database, a database containing 230 million zinc ligand/ionophores for sale as potential drugs to various pharmaceutical companies and has 750 million viewable zinc ionophores is funded by NIH of which Fauci is the head.

 

My recent sleuthing into Remdesivir using the Pharmacology Database and comparing homologue/analogue organic structure similarities for binding sites of zinc, show that Remdesivir is also a zinc ligand/ ionophore (carrier molecule). Gilead has not shared that information with the public but I’m quite sure that Gilead Pharmacology Chemist are very aware that Remdesivir is a ligand ionophore for zinc and can help transport zinc across cell membranes to interfere with viral RNA RdRp enzyme and prevent further virion reproduction just like its HCQ competitor. Gilead synthesized Remdesivir so that it mimics ATP which is critical for RNA reproduction . Since Remdesivir’s organic structure is slightly different from ATP, incorporation of its biological transformed homologue or its synthetic structure depicted below by the virus interrupts RNA transcription and produces pieces of viral RNA which can not be reassembled to make new viruses.

 

I believe that Gilead is not promoting/touting Remdesivir as a zinc ionophore because its afraid of losing out to HCQ which is one hundred times less expensive since its patent ran out many years ago and is currently produced in 12 different pharmacology labs in India.

 

Gilead has spent $ hundreds of millions in research/marketing/propaganda, and Gilead stands to lose $ Billions in sales as one 5 day treatment costs $2340.

 

I’m attaching a graphic which shows the chemical structures of zinc ionophores. Adenosine, ATP, Quercetin, HCQ, and Remdesivir. Zn is shown bound to Hydroxyl (OH) molecules which are present in every structure on the below Structures.